Improved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studies

References

• Aktaş, Y., et al., 2005. Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor. International Journal of Pharmaceutics, 298(2), 378–383.
   PubMed Web of Science ®Google Scholar
• Avadi, M.R., et al., 2010. Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method. Nanomedicine, 6(1), 58–63.
   PubMed Web of Science ®Google Scholar
• Biao, L., et al., 2017. Synthesis, characterization and antibacterial study on the chitosan-functionalized Ag nanoparticles. Materials Science and Engineering: C, 76, 73–80.
   PubMed Web of Science ®Google Scholar
• Bitto, A., et al., 2008. Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol. British Journal of Pharmacology, 155(6), 896–905.
   PubMed Web of Science ®Google Scholar
• Calvo, P., et al., 1997. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharmaceutical Research, 14(10), 1431–1436.
   PubMed Web of Science ®Google Scholar
• Colucci, S., et al., 1998. Alendronate reduces adhesion of human osteoclast-like cells to bone and bone protein-coated surfaces. Calcified Tissue International, 63(3), 230–235.
   PubMed Web of Science ®Google Scholar
• Csaba, N., Köping-Höggård, M., and Alonso, M.J., 2009. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. International Journal of Pharmaceutics, 382(1–2), 205–214.
   PubMed Web of Science ®Google Scholar
• de Melo, N.F.S., et al., 2013. Factorial design and characterization studies for articaine hydrochloride loaded alginate/chitosan nanoparticles. Journal of Colloid Science and Biotechnology, 2(2), 146–152.
   Google Scholar
• Deepthi, S., et al., 2016. An overview of chitin or chitosan/nano ceramic composite scaffolds for bone tissue engineering. International Journal of Biological Macromolecules, 93(Pt B), 1338–1353.
   PubMed Web of Science ®Google Scholar
• Dmour, I., and Taha, M.O., 2017. Novel nanoparticles based on chitosan-dicarboxylate conjugates via tandem ionotropic/covalent crosslinking with tripolyphosphate and subsequent evaluation as drug delivery vehicles. International Journal of Pharmaceutics, 529(1–2), 15–31.
   PubMed Web of Science ®Google Scholar
• Donmez, B.O., et al., 2012. Effect of angiotensin II type 1 receptor blocker on osteoporotic rat femurs. Pharmacological Reports, 64(4), 878–888.
   PubMed Web of Science ®Google Scholar
• Duranova, H., et al., 2014. Changes in compact bone microstructure of rats subchronically exposed to cadmium. Acta Veterinaria Scandinavica, 56, 64.
   PubMed Web of Science ®Google Scholar
• El-Hefian, E.A., Nasef, M.M., and Yahaya, A.H., 2011. Preparation and characterization of chitosan/poly(vinyl alcohol) blended films: mechanical, thermal and surface investigations. E-Journal of Chemistry, 8, 91-96.
   Google Scholar
• Fazil, M., et al., 2016. Biodegradable intranasal nanoparticulate drug delivery system of risedronate sodium for osteoporosis. Drug Delivery, 23, 2428–2438.
   PubMed Web of Science ®Google Scholar
• Fernandez-Urrusuno, R., et al., 1999. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharmaceutical Research, 16, 1576–1581.
   PubMed Web of Science ®Google Scholar
• Friesner, R.A., et al., 2004. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749.
   PubMed Web of Science ®Google Scholar
• Georgiadis, M., Muller, R., and Schneider, P., 2016. Techniques to assess bone ultrastructure organization: orientation and arrangement of mineralized collagen fibrils. Journal of the Royal Society Interface, 13, 1-26.
   Web of Science ®Google Scholar
• Gomathi, T., et al., 2017. Fabrication of letrozole formulation using chitosan nanoparticles through ionic gelation method. International Journal of Biological Macromolecules, 104, 1820–1832.
   PubMed Web of Science ®Google Scholar
• Hohenhaus, M.H., Mcgarry, K.A., and Col, N.F., 2007. Hormone therapy for the prevention of bone loss in menopausal women with osteopenia: is it a viable option? Drugs, 67(16), 2311–2321.
   PubMed Web of Science ®Google Scholar
• Howard, K.A., et al., 2009. Chitosan/siRNA nanoparticle–mediated TNF-α knockdown in peritoneal macrophages for anti-inflammatory treatment in a Murine Arthritis Model. Molecular Therapy, 17(1), 162–168.
   PubMed Web of Science ®Google Scholar
• Javia, A., and Thakkar, H., 2017. Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation. Journal of Microencapsulation, 34(7), 644–658.
   PubMed Web of Science ®Google Scholar
• Johnell, O., and Kanis, J.A., 2006. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis International, 17(12), 1726–1733.
   PubMed Web of Science ®Google Scholar
• Kalu, D.N., et al., 1991. Skeletal response of ovariectomized rats to low and high doses of 17β-estradiol. Bone and Mineral, 14(3), 175–187.
   PubMedGoogle Scholar
• Kawai, M., et al., 2011. Emerging therapeutic opportunities for skeletal restoration. Nature Reviews Drug Discovery, 10(2), 141.
   PubMed Web of Science ®Google Scholar
• Kean, T., and Thanou, M., 2010. Biodegradation, biodistribution and toxicity of chitosan. Advanced Drug Delivery Reviews, 62(1), 3–11.
   PubMed Web of Science ®Google Scholar
• Khajuria, D.K., et al., 2013. Osteoprotective effect of propranolol in ovariectomized rats: a comparison with zoledronic acid and alfacalcidol. Journal of Orthopaedic Science, 18(5), 832–842.
   PubMed Web of Science ®Google Scholar
• Khajuria, D.K., et al., 2014a. Prophylactic effects of propranolol versus the standard therapy on a new model of disuse osteoporosis in rats. Scientia Pharmaceutica, 82(2), 357–374.
   PubMedGoogle Scholar
• Khajuria, D.K., Razdan, R., and Mahapatra, D.R., 2011. Drugs for the management of osteoporosis: a review. Rev Bras Reumatol, 51(4), 365–371. 379–82.
   PubMedGoogle Scholar
• Khajuria, D.K., Razdan, R., and Mahapatra, D.R., 2012. Description of a new method of ovariectomy in female rats. Rev Bras Reumatol, 52(3), 462–470.
   PubMed Web of Science ®Google Scholar
• Khajuria, D.K., Razdan, R., and Mahapatra, D.R., 2014b. Zoledronic acid in combination with alfacalcidol has additive effects on trabecular microarchitecture and mechanical properties in osteopenic ovariectomized rats. Journal of Orthopaedic Science, 19(4), 646–656.
   PubMed Web of Science ®Google Scholar
• Khajuria, D.K., Razdan, R., and Mahapatra, D.R., 2015. Development, in vitro and in vivo characterization of zoledronic acid functionalized hydroxyapatite nanoparticle based formulation for treatment of osteoporosis in animal model. European Journal of Pharmaceutical Sciences, 66, 173–183.
   PubMed Web of Science ®Google Scholar
• Khatun, B., et al., 2018. Genipin crosslinked curcumin loaded chitosan/montmorillonite K-10 (MMT) nanoparticles for controlled drug delivery applications. Journal of Microencapsulation, 35(5), 439–453.
   PubMed Web of Science ®Google Scholar
• Kim, D.G., et al., 2006. Retinol-encapsulated low molecular water-soluble chitosan nanoparticles. International Journal of Pharmaceutics, 319(1–2), 130–138.
   PubMed Web of Science ®Google Scholar
• Kumar, N., et al., 2018. Synthesis, characterization and anticancer activity of vincristine loaded folic acid-chitosan conjugated nanoparticles on NCI-H460 non-small cell lung cancer cell line. Egyptian Journal of Basic and Applied Sciences, 5 (1), 87–99.
   Google Scholar
• Loftsson, T., Matthíasson, K., and Másson, M., 2003. The effects of organic salts on the cyclodextrin solubilization of drugs. International Journal of Pharmaceutics, 262(1–2), 101–107.
   PubMed Web of Science ®Google Scholar
• Logithkumar, R., et al., 2016. A review of chitosan and its derivatives in bone tissue engineering. Carbohydrate Polymers, 151, 172–188.
   PubMed Web of Science ®Google Scholar
• Ma, K., et al., 2014. Osteogenetic property of a biodegradable three-dimensional macroporous hydrogel coating on titanium implants fabricated via EPD. Biomedical Materials, 9(1), 015008.
   PubMed Web of Science ®Google Scholar
• Martínez, A., et al., 2013. Synthesis and characterisation of alginate/chitosan nanoparticles as tamoxifen controlled delivery systems. Journal of Microencapsulation, 30(4), 398–408.
   PubMed Web of Science ®Google Scholar
• Miladi, K., et al., 2015. Enhancement of alendronate encapsulation in chitosan nanoparticles. Journal of Drug Delivery Science and Technology, 30, 391–396.
   Web of Science ®Google Scholar
• Mitchell, D.Y., et al., 2001. Risedronate pharmacokinetics and intra- and inter-subject variability upon single-dose intravenous and oral administration. Pharmaceutical Research, 18(2), 166–170.
   PubMed Web of Science ®Google Scholar
• Mubarakali, D., et al., 2018. An inhibitory action of chitosan nanoparticles against pathogenic bacteria and fungi and their potential applications as biocompatible antioxidants. Microbial Pathogenesis, 114, 323–327.
   PubMed Web of Science ®Google Scholar
• Mukherjee, D., et al., 2018a. Development and characterization of chitosan-based hydrogels as wound dressing materials. Journal of Drug Delivery Science and Technology, 46, 498–510.
   Web of Science ®Google Scholar
• Mukherjee, D., et al., 2018b. Improvement of bone microarchitecture in methylprednisolone induced rat model of osteoporosis by using thiolated chitosan-based risedronate mucoadhesive film. Drug Development and Industrial Pharmacy, 44(11), 1845–1856.
   PubMed Web of Science ®Google Scholar
• Mukherjee, D., and Bharath, S., 2013. Design and characterization of double layered mucoadhesive system containing bisphosphonate derivative. ISRN pharmaceutics, 2013, 604690.
   PubMedGoogle Scholar
• Ogawa, K., et al., 2005. Effects of combined elcatonin and alendronate treatment on the architecture and strength of bone in ovariectomized rats. Journal of Bone and Mineral Metabolism, 23(5), 351–358.
   PubMed Web of Science ®Google Scholar
• Papadimitriou, S., et al., 2008. Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydrate Polymers, 73(1), 44–54.
   Web of Science ®Google Scholar
• Pourshahab, P.S., et al., 2011. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid. Journal of Microencapsulation, 28(7), 605–613.
   PubMed Web of Science ®Google Scholar
• Ragerdi Kashani, I., et al., 2009. Prevention of methylprednisolone acetate-induced osteoporosis with calcium administration in rat model. Acta medica iranica, 47(4), 251–257.
   Google Scholar
• Raichur, V., et al., 2017. Zolendronic acid-conjugated PLGA ultrasmall nanoparticle loaded with methotrexate as a supercarrier for bone-targeted drug delivery. AAPS PharmSciTech, 18(6), 2227–2239.
   PubMed Web of Science ®Google Scholar
• Rampino, A., et al., 2013. Chitosan nanoparticles: preparation, size evolution and stability. International Journal of Pharmaceutics, 455(1–2), 219–228.
   PubMed Web of Science ®Google Scholar
• Rogers, M.J., et al., 1999. Molecular mechanisms of action of bisphosphonates. Bone, 24(5 Suppl), 73s–79s.
   PubMed Web of Science ®Google Scholar
• Russell, R.G., et al., 1999. The pharmacology of bisphosphonates and new insights into their mechanisms of action. Journal of Bone and Mineral Research, 14 Suppl 2(Suppl 2), 53–65.
   PubMed Web of Science ®Google Scholar
• Sahana, H., et al., 2013. Improvement in bone properties by using risedronate adsorbed hydroxyapatite novel nanoparticle based formulation in a rat model of osteoporosis. Journal of Biomedical Nanotechnology, 9(2), 193–201.
   PubMed Web of Science ®Google Scholar
• Saini, D., et al., 2015. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis. Drug delivery, 22(6), 823–836.
   PubMed Web of Science ®Google Scholar
• Sato, M., et al., 1991. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. Journal of Clinical Investigation, 88(6), 2095–2105.
   PubMed Web of Science ®Google Scholar
• Savitri, E., et al., 2014. Degradation of chitosan by sonication in very-low-concentration acetic acid. Polymer Degradation and Stability, 110, 344–352.
   Web of Science ®Google Scholar
• Shahnazari, M., et al., 2010. Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats. Bone, 46(5), 1267–1274.
   PubMed Web of Science ®Google Scholar
• Sherje, A.P., et al., 2017. Inclusion complexation of etodolac with hydroxypropyl-beta-cyclodextrin and auxiliary agents: formulation characterization and molecular modeling studies. Molecular Pharmaceutics, 14(4), 1231–1242.
   PubMed Web of Science ®Google Scholar
• Tabassum, H., and Ahmad, I.Z., 2018. Evaluation of the anticancer activity of sprout extract-loaded nanoemulsion of N. sativa against hepatocellular carcinoma. Journal of Microencapsulation, 35(7–8), 643–656.
   PubMed Web of Science ®Google Scholar
• Urandur, S., et al., 2018. Anisamide-anchored lyotropic nano-liquid crystalline particles with AIE effect: a smart optical beacon for tumor imaging and therapy. ACS Applied Materials and Interfaces, 10, 12960–12974.
   PubMed Web of Science ®Google Scholar
• Vila, A., et al., 2004. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. European Journal of Pharmaceutics and Biopharmaceutics, 57(1), 123–131.
   PubMed Web of Science ®Google Scholar
• Wang, H., George, G., and Islam, N., 2018. Nicotine-loaded chitosan nanoparticles for dry powder inhaler (DPI) formulations – Impact of nanoparticle surface charge on powder aerosolization. Advanced Powder Technology, 29(12), 3079–3086.
   Web of Science ®Google Scholar
• Wells, G.A., et al., 2008. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database of Systematic Reviews, (1), CD001155. DOI:10.1002/14651858.CD001155.pub2.
   Web of Science ®Google Scholar
• Wu, Y., et al., 2017. Facile fabrication of poly(acrylic acid) coated chitosan nanoparticles with improved stability in biological environments. European Journal of Pharmaceutics and Biopharmaceutics, 112, 148–154.
   PubMed Web of Science ®Google Scholar
• Xu, Y., and Du, Y., 2003. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. International Journal of Pharmaceutics, 250(1), 215–226.
   PubMed Web of Science ®Google Scholar